Gene Query: TMUB2

Dataset Description Geneva Score
Patient-derived luminal breast cancer xenografts with progestins 21.02
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 21.02
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 13.25
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 11.67
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 10.47
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 8.64
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 8.6
Transcriptome of diurnal human blood neutrophils 7.68
The landscape of alternative splicing in aggressive prostate cancers 7.37
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 7.33
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.98
Stem and effector CD8 T-cells from human cancers 6.9
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 6.85
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.81
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 6.79
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 6.79
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 6.38
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 6.27
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.25
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.94
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 5.78
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.74
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 5.73
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 5.73
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.71
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.71
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 5.7
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.61
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.61
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.56
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 5.46
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 5.46
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 5.39
TFAP2C signalling in human fibroblasts 5.36
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.32
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.24
Effect of FGF13 depletion on the H460 cell line 5.21
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.19
Silencing SPIB in attached and floating state of H1703 lung cancer cells 5.19
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 5.19
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 5.05
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.0
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.99
A role for ZNF598 in post-transcriptional gene regulation 4.89
Pharmacologic inhibition of STAT5 in AML 4.88
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 4.88
The evolution of N6-methyladenosine in primates 4.86
Macrophage Ad5f35 M2 Challenge 4.82
Tracking of dCas9-methyltransferase footprints 4.8
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.79
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 4.79
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.76
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.69
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 4.68
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 4.61
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.57
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.48
FOXP2's impact on the primate transcriptome 4.47
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.43
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.43
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.42
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.39
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 4.28
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 4.28
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 4.16
Discovering human diabetes-risk gene function with genetics and physiological assays 4.09
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.04
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.02
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.01
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 4.0
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 4.0
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.97
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.95
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.91
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.91
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.9
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.89
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.89
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 3.83
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 3.83
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.82
Gene expression regulated by CSA and CSB in neuroblastoma cell line 3.8
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.7
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.7
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.68
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 3.66
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.65
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 3.62
RNA expression following TMPRSS11B overexpression or depletion 3.58
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 3.57
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 3.57
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 3.57
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.54
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.53
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.53
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.52
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.5
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.49
RNA Seq of HMVEC under hypoxia 3.49
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.49
Transcriptional effect of ETV1 knockdown in melanoma cells 3.45
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.44
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 3.43
RNA-seq analysis of differentiating human erythroblasts 3.41
Tumor exosome integrins determine organotropic metastasis 3.37
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 3.37
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.36
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.36
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 3.35
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.33
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.26
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.23
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.23
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.23
Gene expression in GBM with Cav3.2 inhibition 3.23
Transciptomic profiling of human fetal lung samples 3.22
The bromodomain protein BRD4 regulates splicing during heat shock 3.22
Gene expression signatures of innate lymphoid cells from human blood 3.21
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.2
IL-33 activates tumor stroma to promote intestinal polyposis 3.17
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.17
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.16
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.16
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.15
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.13
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.12
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.11
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 3.1
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.09
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.07
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.06
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.04
RNA-seq of shEZH2 cells 3.04
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.03
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.02
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.99
Transcriptional responses of human insulinoma cells to acute cytokine exposure 2.98
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.96
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.96
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 2.94
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 2.94
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 2.94
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.91
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 2.89
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 2.89
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 2.88
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.88
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.88
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.87
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 2.86
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.86
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.85
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.84
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.84
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.82
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 2.82
Triple vectors expand AAV transfer capacity in the retina 2.82
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.82
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.81
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 2.81
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.79
Cell responses to dysregulated VZV-induced cell-cell fusion 2.78
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.76
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 2.7
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 2.69
RNA-Seq from human ILC transitional populations 2.69
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.69
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 2.66
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 2.64
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.63
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.63
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 2.62
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.61
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.61
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.6
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.59
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.59
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.58
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.58
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 2.58
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.58
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 2.58
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.56
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 2.54
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 2.49
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 2.48
Identification of a LIF-responsive replication-competent human β cell 2.48
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.46
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 2.44
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.44
Illumina Total RNA-seq in HeLa 2.44
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 2.42
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.4
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 2.38
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 2.38
Single-cell analysis of adult human ovary using 10X genomics 2.38
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.38
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.38
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.38
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.38
RNA-Seq and expression data from human adipose tissue 2.38
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.37
Transcription control by the ENL YEATS domain in acute leukemia 2.37
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 2.37
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.36
RNA-sequencing in immortalized human mammary epithelial cells 2.36
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 2.35
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.33
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.32
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 2.3
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 2.3
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.29
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 2.29
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.28
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.28
quanTIseq: quantifying immune contexture of human tumors 2.24
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 2.24
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 2.23
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 2.22
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 2.18
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 2.18
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.18
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.18
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.17
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.17
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.16
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.16
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.16
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.15
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 2.15
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.15
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.15
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.14
Total RNA-Seq data from leukemic patients with complex structural variants 2.14
RNA-seq differential expression studies: more sequence, or more replication? 2.14
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 2.13
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 2.13
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.12
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.12
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.11
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.11
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.09
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.09
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.08
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.06
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.06
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 2.05
RNA-seq of IL-4 stimulated human keratinocytes 2.04
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.03
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.01
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.01
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.0
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.0
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.0
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.99
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.99
Gene expression activation in CLL mediated by MSCs contact 1.99
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.98
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.98
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 1.97
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.97
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.96
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.95
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.94
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 1.93
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 1.91
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 1.91
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.9
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.88
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 1.84
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.84
Capturing the Interactome of Newly Transcribed RNA 1.84
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.84
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.83
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.82
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.81
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.79
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.78
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.78
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.78
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.78
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.76
X-Ray induced DNA-Hydroxymethylation changes 1.74
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.73
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 1.73
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.72
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 1.7
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.69
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.69
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.69
Transcriptome analysis of peripheral blood monocytes 1.67
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.66
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.66
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.66
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.65
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.65
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.65
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.64
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.63
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.63
Transcriptome analysis of BAP1 knockout and restoration 1.63
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 1.63
KLF6-dependent transcription in renal cancer cells 1.62
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.62
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.62
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.6
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.6
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.59
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.57
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.56
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.56
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.55
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.55
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.54
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.53
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.53
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.52
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 1.52
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.52
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.51
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.51
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.5
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.49
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 1.48
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.47
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.46
BACH2 in human plasma cell fate decision 1.45
An optimization system for isolating and sequencing of single human colon cancer cells 1.44
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.43
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.43
Investigate A2M treatment on human prostate cancer and mouse liver 1.42
Investigate A2M treatment on human prostate cancer xenograft in mice 1.42
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.41
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.41
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.4
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.4
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.4
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.39
Effect of drugs on transcriptomic profiles 1.34
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.34
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.34
Polarized B -cell functions 1.34
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.33
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.32
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.3
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.3
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.29
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.28
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.28
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 1.27
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.26
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.26
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 1.24
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.23
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.23
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.22
RNA-Seq of PRMT1 overexpression ECA109 cells 1.22
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.19
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.14
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.13
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.13
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.13
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.12
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.12
Positively selected enhancer elements endow tumor cells with metastatic competence 1.08
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.08
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.07
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.07
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.06
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.05
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.05
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.03
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.03
Transcriptome wide analysis of classically and alternatively activated macrophages 1.02
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.01
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.01
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.0
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.0
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.98
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.97
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.96
A map of gene expression in neutrophil-like cell lines 0.96
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.94
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.92
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.88
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.86
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.86
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.85
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.84
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.82
Enhancer activation during EGF response 0.81
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.8
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.8
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.8
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.75
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.74
The circadian transcriptional landscape in primary human mammary epithelial cells 0.73
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.71
Transcriptome analysis of CNS leukemia 0.69
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.69
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.66
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.65
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.65
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.63
Preclinical model of obesity and ER-positive breast cancer 0.63
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.62
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.62
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.61
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.59
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.59
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 0.57
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.57
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.55
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.55
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.54
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.54
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.54
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.54
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.53
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.53
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.52
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.52
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.5
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.48
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.47
Determining mRNA half-lives on a transcriptome-wide scale 0.46
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.46
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.45
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.44
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.44
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.43
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.42
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.42
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.41
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.41
Ribosome profiling upon inhibition of eIF4A 0.38
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.38
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.38
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.37
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.37
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.36
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.36
Transcriptional profile in human S. haematobium infection 0.35
Dysregulated immune system networks in war veterans with PTSD 0.33
Transcriptomic analysis of LSD1 0.3
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.29
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.28
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.27
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.27
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.26
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.26
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.25
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.22
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.22
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.22
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.22
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.2
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.2
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.19
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.18
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.17
Gene expression profile in breast cancer cells 0.17
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.17
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.15
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.15
Function and hormonal regulation of GATA3 in human first trimester placentation 0.15
miRNAs affected by antagomiR-17 treatment 0.14
Primary Human B-cell Temporal Response to CD40L Stimulation 0.13
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.12
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.12
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.11
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.11
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.1
The transcriptome and chromatin accessbility landscape of mammalian germline 0.1
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.1
Gene expression analysis of human adenomas. 0.09
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.09
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.09
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 0.08
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.08
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.07
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.07
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.07
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.06
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.05
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.05
Gene expression alterations of pancreatic intraepithlial neoplasia 0.05
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.04
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.04
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.04
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.03
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.03
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.02
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation